Literature DB >> 27758813

Tuberculous meningitis in an immunocompetent male complicated by hydrocephalus.

Louise Dunphy1, Prashanth Shetty2, Rabinder Randhawa2, Kharil Amir Rani3, Yaw Duodu3.   

Abstract

A 39-year-old man, born in India but resident in the UK for 10 years, was travelling in America when he became feverish with an altered mentation. He reported a 10-day history of fever, photophobia, headache and fatigue. His medical history included hypothyroidism and migraine. He was a non-smoker, did not consume alcohol and denied a history of drug use. He was transferred to the emergency department. Laboratory investigations confirmed hyponatraemia (sodium 128 mmol/L). A chest radiograph confirmed no focal consolidation. Further investigation with a CT brain was unremarkable. A lumbar puncture was suggestive of viral meningitis, with a raised white cell count, lymphocytosis, high protein and low glucose. His PCR was negative for enterovirus and herpes simplex virus. Further investigation with a CT thorax, abdomen and pelvis demonstrated bilateral upper-lobe infiltrations. A bronchoalveolar lavage was negative for acid alcohol fast bacilli (AAFB). A diagnosis of tuberculous meningitis was rendered following a repeat lumbar puncture. Gram stain revealed AAFB and PCR was also positive. He started antitubercular treatment and corticosteroids. A repeat CT brain demonstrated ventriculomegaly, suggestive of hydrocephalus and an MRI head revealed likely communicating hydrocephalus with basilar enhancement. He was repatriated to the UK. Eleven days post transfer, he became acutely confused and required external ventricular drain insertion. After surgical management of his hydrocephalus, there was no further neurological deterioration. He remains committed to his neurorehabilitation. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27758813      PMCID: PMC5073708          DOI: 10.1136/bcr-2015-213916

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  STREPTOMYCIN treatment of tuberculous meningitis.

Authors: 
Journal:  Lancet       Date:  1948-04-17       Impact factor: 79.321

2.  Tuberculous encephalopathy with and without meningitis. Clinical features and pathological correlations.

Authors:  P M Udani; D K Dastur
Journal:  J Neurol Sci       Date:  1970-06       Impact factor: 3.181

Review 3.  MR imaging of central nervous system tuberculosis.

Authors:  J R Jinkins; R Gupta; K H Chang; J Rodriguez-Carbajal
Journal:  Radiol Clin North Am       Date:  1995-07       Impact factor: 2.303

Review 4.  Tuberculous meningitis.

Authors:  J M Leonard; R M Des Prez
Journal:  Infect Dis Clin North Am       Date:  1990-12       Impact factor: 5.982

Review 5.  Management of tuberculosis meningitis.

Authors:  M R Holdiness
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

6.  Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults.

Authors:  Guy E Thwaites; Duc Bang Nguyen; Huy Dung Nguyen; Thi Quy Hoang; Thi Tuong Oanh Do; Thi Cam Thoa Nguyen; Quang Hien Nguyen; Tri Thuc Nguyen; Ngoc Hai Nguyen; Thi Ngoc Lan Nguyen; Ngoc Lan Nguyen; Hong Duc Nguyen; Ngoc Tuan Vu; Huu Hiep Cao; Thi Hong Chau Tran; Phuong Mai Pham; Thi Dung Nguyen; Kasia Stepniewska; Nicholas J White; Tinh Hien Tran; Jeremy J Farrar
Journal:  N Engl J Med       Date:  2004-10-21       Impact factor: 91.245

7.  Diagnostic criteria for tuberculous meningitis and their validation.

Authors:  G K Ahuja; K K Mohan; K Prasad; M Behari
Journal:  Tuber Lung Dis       Date:  1994-04

8.  Randomized controlled trial of dexamethasone in tuberculous meningitis.

Authors:  S Kumarvelu; K Prasad; A Khosla; M Behari; G K Ahuja
Journal:  Tuber Lung Dis       Date:  1994-06

Review 9.  Corticosteroids for managing tuberculous meningitis.

Authors:  K Prasad; M B Singh
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

10.  Long-term mortality in patients with tuberculous meningitis: a Danish nationwide cohort study.

Authors:  Anne-Sophie Halkjær Christensen; Casper Roed; Lars Haukali Omland; Peter Henrik Andersen; Niels Obel; Åse Bengaard Andersen
Journal:  PLoS One       Date:  2011-11-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.